Neurocrine Biosciences Inc NBIX:NASDAQ

Last Price$84.88NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/16/22

Today's Change+0.76(0.90%)
Bid (Size)$80.43 (14)
Ask (Size)$85.40 (7)
Day Low / High$82.82 - 85.23
Volume496.2 K

Neurocrine Biosciences Preliminary Ingrezza Sales Up 25% in Q4'21

4:28PM ET 1/06/2022 MT Newswires
Neurocrine Biosciences (NBIX) on Thursday reported preliminary Ingrezza drug sales of about $301 million for Q4 and about $1.1 billion for the full year 2021.

Ingrezza sales and total prescriptions grew 25% and 32% respectively in Q4 from a year ago, the drugmaker said. The drug is indicated to treat adults with tardive dyskinesia, a condition linked to uncontrollable, abnormal, and repetitive movements of the face, torso, and/or other body parts.

Neurocrine plans to provide full-year 2022 Ingrezza sales guidance in its Q4 results on Feb. 11.

Price: 82.5, Change: -0.03, Percent Change: -0.04